Joseph DeBruin

Joseph DeBruin

Auto-generated profile, based on publicly available information

Joseph DeBruin

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2015 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
EBEmily G. Baxi
Emily G. Baxi
JDJoseph DeBruin
Joseph DeBruin
DTDominique Tosi
Dominique Tosi
IGInna V. Grishkan
Inna V. Grishkan
MSMatthew D. Smith
Matthew D. Smith
AGAnne R. Gocke
Anne R. Gocke
Multiple sclerosis (MS) is a demyelinating disease of the CNS characterized by inflammation and neurodegeneration. Animal models that enable the study of remyelination in the context of ongoing inflammation are greatly needed for the development of novel therapies that target the pathological inhibitory cues inherent to the MS plaque microenvironment. We report the development of an innovative animal model combining cuprizone-mediated demyelination with transfer of myelin-reactive CD4+T cells. Characterization of this model reveals both Th1 and Th17 CD4+T cells infiltrate the CNS of cuprizone-fed mice, with infiltration of Th17 cells being more efficient. Infiltration correlates with impaired spontaneous remyelination as evidenced by myelin protein expression, immunostaining, and ultrastructural analysis. Electron microscopic analysis further reveals that demyelinated axons are preserved but reduced in caliber. Examination of the immune response contributing to impaired remyelination highlights a role for peripheral monocytes with an M1 phenotype. This study demonstrates the development of a novel animal model that recapitulates elements of the microenvironment of the MS plaque and reveals an important role for T cells and peripheral monocytes in impairing endogenous remyelinationin vivo. This model could be useful for testing putative MS therapies designed to enhance remyelination in the setting of active inflammation, and may also facilitate modeling the pathophysiology of denuded axons, which has been a challenge in rodents because they typically remyelinate very quickly.